Old Web
English
Sign In
Acemap
>
authorDetail
>
M. Vermeer
M. Vermeer
Loyola University Medical Center
Immunology
Medicine
Mycosis fungoides/Sezary syndrome
Biology
KIR3DL2
3
Papers
8
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
516 Global collaboration for establishment of a prognostic index in mycosis fungoides & Sezary Syndrome
2018
Journal of Investigative Dermatology
J. Scarisbrick
Pietro Quaglino
M. Vermeer
H. M. Prince
Evangelia Papadavid
Emmilia Hodak
Sean Whittaker
M. Bagot
Pablo Ortiz
Rudolf Stadler
Robert Knobler
Felicity Evison
E. Hong
R. Willemze
Youn H. Kim
Show All
Source
Cite
Save
Citations (0)
Immunothérapie ciblée des lymphomes T cutanés par IPH4102, un anticorps monoclonal « first-in-class » dirigé contre la molécule KIR3DL2 : étude de phase I internationale multicentrique
2018
Annales De Dermatologie Et De Venereologie
M. Bagot
Anne Marie-Cardine
C. Ram-Wolff
Pierluigi Porcu
Michael S. Khodadoust
Basem M. William
N. Thonnart
M. Vermeer
Sean Whittaker
M. Duvic
Armand Bensussan
Cécile Bonnafous
Hélène Sicard
Christine Paiva
M. Battistella
Youn H. Kim
Show All
Source
Cite
Save
Citations (0)
Phase I Study of IPH4102, Anti-KIR3DL2 Mab, in Relapsed/Refractory Cutaneous T-Cell Lymphomas (CTCL): Dose-escalation Safety, Biomarker and Clinical Activity Results
2017
Hematological Oncology
M. Bagot
Pierluigi Porcu
C. Ram-Wolff
Michael S. Khodadoust
W. Basem
Maxime Battistella
Anne Marie-Cardine
M. Vermeer
S. Mathieu
S. Whittaker
M. Duvic
Armand Bensussan
Carine Paturel
Cécile Bonnafous
N. Thonnart
A. Widemann
Cecile Bonin
Hélène Sicard
Christine Paiva
Korinna Pilz
Youn H. Kim
Show All
Source
Cite
Save
Citations (8)
1